Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 2—February 2011
CME ACTIVITY - Synopsis

Hepatitis E Virus and Neurologic Disorders

Nassim KamarComments to Author , Richard P. Bendall, Jean Marie Peron, Pascal Cintas, Laurent Prudhomme, Jean Michel Mansuy, Lionel Rostaing, Frances Keane, Samreen Ijaz, Jacques Izopet, and Harry R. Dalton
Author affiliations: Author affiliations: Centre Hospitalier Universitaire Rangueil, Toulouse, France (N. Kamar, P. Cintas, L. Rostaing); Université Paul Sabatier, Toulouse (N. Kamar, J.M. Peron, L. Rostaing, J. Izopet); Royal Cornwall Hospital Trust, Truro, UK (R.P. Bendall, F. Keane, H.R. Dalton); Centre Hospitalier Universitaire Purpan, Toulouse (J.M. Peron, J.M. Mansuy, J. Izopet); Centre Hospitalier de Castres, Castres, France (L. Prudhomme); Health Protection Agency, London, UK (S. Ijaz); Peninsula College of Medicine and Dentistry, Truro (H.R. Dalton)

Main Article

Table 1

Summary of 7 cases of HEV–associated neurologic disorders, Cornwall, UK, and Toulouse, France*

Patient no. Relevant medical status HEV infection phase† HEV genotype Serum
 Cerebrospinal fluid
HEV IgG/IgM HEV RNA ALT,
IU/L† Bilirubin, µmol/L HEV RNA Protein level, g/L Leukocytes, cells/mm3
1 Not immunocompromised Acute 3e +/+ + 623 14 – 1.27 145
2 Not immunocompromised Acute 3e +/+ + 1160 70 ND – –
3 Not immunocompromised Acute 3f +/+ + 384 35 – 2 14
4 Kidney–pancreas transplant recipient Chronic 3f +/+ + 173 19 + 0.71 1
5 Kidney transplant recipient Chronic 3f –/+ + 110 12 + 0.8 8
6 Kidney transplant recipient Chronic 3f +/+ + 105 12 + 0.76 7
7‡ HIV positive Chronic 3a +/+ + 150 9 + 0.47 1

*HEV, hepatitis E virus; Ig, immunoglobulin; ALT, alanine aminotransferase; +, positive; –, negative; ND, not done.
†At time of examination for neurologic symptoms.
‡This patient had positive IgG and IgM Wantai assay results throughout but had negative HEV IgG and IgM results for 3 separate Genelabs assays during 2007–2008.

Main Article

Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external